📡 Longevity Marketcap Telemetry (March 15th, 2021)

1. Announcements

2. Last Week in Longevity

3. Longevity Futures

4. Longevity Jobs

5. Tweet of the Week

*Disclaimer: None of this should be taken as financial advice. It is for educational purposes only.

**Resources: Longevity Clinical Trial Tracker // Longevity Industry Database

📢 Announcements

1. The newsletter will be split into two separate publications (both free) going forward:

   1. Longevity Marketcap Telemetry - A weekly review of major developments in the longevity industry, upcoming events, jobs, investment opportunities (“Deal Flow”), and short observations. 

   2. Longevity Marketcap Reports - A more in-depth research report on longevity companies and their underlying science published every 1 - 2 weeks. Easier to use as reference material now that all the extraneous news and events are moved to a separate publication (see above). 

2. I started a Patreon account. This newsletter and the LMC research reports will always be free. But if you believe in me and my mission to grow a wave of passionate people building, funding, and championing technologies that will accelerate the end of aging then please consider supporting. Your funding will help me pay for web server costs, graphic design and video production tools, and perhaps hire some extra help in the future

Special note: PEARL Trial by AgelesssRX

AgelessRX, a DTC online pharmacy for anti-aging compounds, is crowdfunding a 200-person Phase 4 clinical trial of rapamycin. Rapamycin is one of the most well-studied anti-aging drugs (for mice it extends lifespan ~ +15%). But because it is off-patent there is no profit incentive for pharma companies to conduct a clinical trial. 

AgelessRX is looking to raise a total of $800k from two sources: 

1. Trial participants ($1000 / each) who will receive $3000 worth of biomarker testing during the trial (DNA methylation clock, blood tests, glycation age test, DEXA scans, gut microbiome sequencing, etc) 

2. Donations from individuals and organizations. 

It appears AgelessRX is only $200k away from reaching its goal for donations. If you are interested in either enrolling for the trial or donating please check out the PEARL trial webpage.

📝 Last Week in Longevity

• Maximon, Swiss-based venture builder, to invest 50M+ in longevity companies over four years. Founded by notable entrepreneur-investors Marc Bernegger, Tobias Reichmuth, and Jörg Rieker, Maximon aims to partner with entrepreneurs to build longevity companies from scratch. Bernegger and Reichmuth are also the organizers of the Longevity Investors Conference.
  
  So